Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
23,451 articles
📰
Stock futures roar higher as Trump calls off Iran strike ultimatum
Per Yahoo! Finance: US stocks were poised for yet another bruising day on Monday as Iran and President Trump traded war threats, raising tensions...
📰
The Market Is Panicking About Shopify and AI -- Here's Why I'm Buying the Dip
Don't let AI disruption fears get in the way of this excellent long-term opportunity.
Dow futures jump 1,100 points as Trump signals pause in Iran strikes
US stock futures witnessed a sharp jump on Monday after US President Donald Trump said Washington and Tehran had held “productive” talks over the...
📰
Shift4 Payments’ (FOUR) Revenue Per Share Increased by 122% Over the Past Three Years - Yahoo Finance
Shift4 Payments’ (FOUR) Revenue Per Share Increased by 122% Over the Past Three Years Yahoo Finance
📰
Shift4 Payments’ (FOUR) Revenue Per Share Increased by 122% Over the Past Three Years
Marram Investment Management, an outsourced long-term investment solutions provider, released its fourth-quarter investor letter. A copy of the...
Trump Postpones Iran Energy Target Strikes for Five Days
President Donald Trump ordered the Pentagon to postpone military strikes against Iranian power plants and energy infrastructure for a five-day...
Trump Says U.S. And Iran Held ‘Productive Conversations’ To End Hostilities
The president also said he has ordered the Pentagon to postpone military strikes on Iran’s power plants for at least 5 days, extending a deadline he...
📰
Oil tumbles after Trump postpones U.S. strikes against Iran energy infrastructure for five days
Oil prices tumbled Monday after President Donald Trump said the U.S. and Iran had productive talks, leading him to order a halt on strikes against...
📰
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
Ms. McDonough previously served as Senior Vice President of Patient Access, Analytics, and Operations at Krystal Biotech (NASDAQ:KRYS), where she...
📰
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
Ms. McDonough previously served as Senior Vice President of Patient Access, Analytics, and Operations at Krystal Biotech (NASDAQ:KRYS), where she...
📰
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
XTX501, a potential best-in-class bispecific PD-1 / masked IL-2, on track for planned IND submission in mid-2026 and Phase 1 initiation in the second...
📰
SL Green Realty Corp. Announces Annual Ordinary Dividend of $2.47 per Share
NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan's largest office landlord, announced today that its...
Ex-Goldman Banker’s AI Chip Company Secures SoftBank Funding
Kandou AI, an artificial-intelligence chip company led by a former Goldman Sachs Group Inc. managing director, raised $225 million from investors...
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis
IRVINE, Calif., March 23, 2026 /PRNewswire/ -- EndoCyclic Therapeutics, a biopharmaceutical company developing precision peptide therapeutics and...
📰
BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions
PALO ALTO, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a biopharmaceutical...
📰
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Rese-cel myositis BLA submission on track for 2027 based on a 17-patient, single arm registrational cohort design, including an outpatient dosing...
📰
Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease
New data show brain-volume preservation correlates with patient outcomes
📰
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Strong financial position with cash, cash equivalents and marketable securities of $91.5M as of December 2025
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
Highlighting Positive Results in Comparison to Valchlor® and in Real-World Use PRINCETON, N.J., March 23, 2026 /PRNewswire/ -- Soligenix, Inc....
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis
IRVINE, Calif., March 23, 2026 /PRNewswire/ -- EndoCyclic Therapeutics, a biopharmaceutical company developing precision peptide therapeutics and...